COMMUNIQUÉS West-GlobeNewswire

Momenta Pharmaceuticals Reports Positive Top-Line Phase 1 Data Showing Proof of Mechanism for M281, an Anti-FcRn Monoclonal Antibody, in Healthy Volunteers
05/01/2018
CAMBRIDGE, Mass., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA ), a biotechnology company specializing in the characterization and engineering of complex drugs, today reported positive [...]
BeyondSpring to Present at the 10th Annual Biotech Showcase
05/01/2018
NEW YORK, Jan. 05, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ) (“BeyondSpring” or the “Company”), a late-stage clinical biopharmaceutical company focusing on the development and commercialization of a [...]
Obalon Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Full Year 2017
05/01/2018
SAN DIEGO, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ) today reported that it achieved preliminary, unaudited revenue of approximately $3.9 million for the fourth quarter ended December [...]
Molecular Templates Provides Corporate Update and Outlines 2018 Milestones
05/01/2018
Takeda Nominated Two Targets Under Research Collaboration in Dec. 2017 Updated MT-3724 Clinical Results Expected in 1H18 At Least Two New MTEM Products to Enter the Clinic in 2018 AUSTIN, Texas, Jan. 05, 2018 (GLOBE [...]
Aduro Biotech Announces Management Changes
05/01/2018
BERKELEY, Calif., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO ) a biopharmaceutical company with three distinct immunotherapy technologies, today announced that Jennifer Lew has been promoted to [...]
Retrophin and Censa Pharmaceuticals Enter into Strategic Collaboration to Advance CNSA-001 for the Treatment of Phenylketonuria (PKU)
05/01/2018
Retrophin obtains exclusive option to purchase Censa post proof-of-concept study Phase 2 proof-of-concept study in PKU patients expected to commence in mid-2018 SAN DIEGO, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Retrophin, [...]
Helius Medical Technologies Selects Key Tronic Corporation as its Commercial Contract Manufacturing Partner
05/01/2018
NEWTOWN, Pa., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX: HSM ) (TSX:HSM.WT) (OTCQB:HSDT) (“Helius” or the “Company”), a medical technology company focused on neurological wellness, [...]
Zealand Pharma to attend Oddo BHF Forum on January 12, 2018
05/01/2018
Press release - No. 1 / 2018 Zealand Pharma to attend Oddo BHF Forum on January 12, 2018 Copenhagen, 5 January, 2018 - Mats Blom, Executive Vice President and Chief Financial Officer (CFO) of Zealand Pharma, will be [...]
Biohit Oyj’s comments on its Chinese distributor’s announcement
05/01/2018
Biohit Oyj company release 5.1.2018 klo 14:30 local time (EEST) Biohit Oyj does not normally comment on its distributors or other third parties announcements, but due to details presented in the media and the potential [...]
ObsEva SA to Participate in JP Morgan Healthcare Conference January 8 - 11, 2018
05/01/2018
Geneva, Switzerland and Boston, MA - January 5, 2018 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]
miRagen Therapeutics Expands Board of Directors with Appointment of Arlene Morris
05/01/2018
BOULDER, Colo., Jan. 05, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN ), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, announced [...]
Idera Pharmaceuticals Provides 2018 Update and Outlook
05/01/2018
EXTON, Pa. and CAMBRIDGE, Mass., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of [...]
AxoGen to Participate at AAHS ASPN ASRM 2018 Annual Meetings
05/01/2018
ALACHUA, Fla., Jan. 05, 2018 (GLOBE NEWSWIRE) -- AxoGen Corporation (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for peripheral nerve damage, today announced its [...]
Surgery Partners Announces Appointment of Wayne S. DeVeydt as Chief Executive Officer
05/01/2018
NASHVILLE, Tenn., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: SGRY ) (the “Company”), a leading healthcare services company, today announced the appointment of Wayne S. DeVeydt as Chief Executive [...]
Axovant to Present at 36th Annual J.P. Morgan Healthcare Conference
05/01/2018
BASEL, Switzerland, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Axovant Sciences (NASDAQ: AXON ) today announced that its Chief Executive Officer David Hung, MD, will be presenting at the 36th Annual J.P. Morgan Healthcare [...]
Natus Appoints Leslie McDonnell as Vice President and General Manager of its Newborn Care Business Unit
05/01/2018
PLEASANTON, Calif., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY ) today announced it has named Leslie McDonnell as Vice President and General Manager of its Newborn Care Business Unit. Ms [...]
Zafgen Reports Strong Clinical Progress and Updates Outlook for 2018
05/01/2018
ZGN-1061 Phase 2 trial fully enrolled with type 2 diabetes patients; topline data expected mid-year Company returning to rare disorders with ZGN-1258; Prader-Willi syndrome expected as first indication Increased cash [...]
Dentsply Sirona to Present at the 36th Annual J.P. Morgan Healthcare Conference
05/01/2018
YORK, Pa., Jan. 05, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY ), The Dental Solutions Company™, today announced that the company will present at the 36 th Annual J.P. Morgan [...]
Chimerix Initiates AdAPT Study for Oral Brincidofovir and Advances IV Brincidofovir to Patient Studies
05/01/2018
- Pivotal AdAPT Study of Oral Brincidofovir for Adenovirus Now Enrolling - - No GI Adverse Effects for IV Brincidofovir 10 mg - - Announces First Antiviral Specific for Norovirus Now In Clinical Testing - DURHAM, N.C., [...]

Pages